Literature DB >> 21889142

Allograft bone matrix versus synthetic bone graft substitutes.

Gerald Zimmermann1, Arash Moghaddam.   

Abstract

Autologous bone is used very often in the treatment of fresh fractures, delayed unions and non-unions. Alternatives have included allografts and in recent years also demineralized bone matrix. The growing availability of good synthetic bone grafts and their advantages in safety and avoiding donor-site morbidity are the reasons that these products are being used more and more. There are on the market a wide variety of substitutes with different capabilities. Nevertheless autologous bone graft is still considered as the gold standard and will be discussed here in that context. Osteoconductive, osteogenic and osteoinductive products will also be classified and their advantages and disadvantages described.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21889142     DOI: 10.1016/j.injury.2011.06.199

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  79 in total

1.  Mineralized collagen scaffolds induce hMSC osteogenesis and matrix remodeling.

Authors:  Daniel W Weisgerber; Steven R Caliari; Brendan A C Harley
Journal:  Biomater Sci       Date:  2015-03       Impact factor: 6.843

2.  Bioprinted osteon-like scaffolds enhance in vivo neovascularization.

Authors:  Charlotte Piard; Hannah Baker; Timur Kamalitdinov; John Fisher
Journal:  Biofabrication       Date:  2019-03-28       Impact factor: 9.954

3.  Long-term in vivo experimental investigations on magnesium doped hydroxyapatite bone substitutes.

Authors:  M Sartori; G Giavaresi; M Tschon; L Martini; L Dolcini; M Fiorini; D Pressato; M Fini
Journal:  J Mater Sci Mater Med       Date:  2014-02-20       Impact factor: 3.896

4.  The mechanism research of non-Smad dependent TAK1 signaling pathway in the treatment of bone defects by recombination BMP-2-loaded hollow hydroxyapatite microspheres/chitosan composite.

Authors:  Jingtang Li; Shilang Xiong; Linghua Ding; Jianhua Zeng; Peng Qiu; Jianguo Zhou; Xingen Liao; Long Xiong
Journal:  J Mater Sci Mater Med       Date:  2019-11-27       Impact factor: 3.896

5.  Platelet Rich Plasma for Traumatic Non-Union Fractures: A Novel butControversial Bone Regeneration Strategy.

Authors:  Fariborz Ghaffarpasand; Maryam Dehghankhalili; Mostafa Shahrezaei
Journal:  Bull Emerg Trauma       Date:  2013-07

6.  The inclusion of zinc into mineralized collagen scaffolds for craniofacial bone repair applications.

Authors:  Aleczandria S Tiffany; Danielle L Gray; Toby J Woods; Kiran Subedi; Brendan A C Harley
Journal:  Acta Biomater       Date:  2019-05-21       Impact factor: 8.947

7.  Remineralized bone matrix as a scaffold for bone tissue engineering.

Authors:  Matthew A Soicher; Blaine A Christiansen; Susan M Stover; J Kent Leach; Clare E Yellowley; Leigh G Griffiths; David P Fyhrie
Journal:  J Biomed Mater Res A       Date:  2014-02-26       Impact factor: 4.396

8.  Advances in 3D Modeling: Preoperative Templating for Revision Wrist Surgery.

Authors:  Liza Osagie; Shalin Shaunak; Aasim Murtaza; Sonja Cerovac; Shamim Umarji
Journal:  Hand (N Y)       Date:  2016-11-29

9.  Adhesion, proliferation and differentiation of human mesenchymal stem cell on chitosan/collagen composite scaffold.

Authors:  Md Abdul Kafi; Mst Khudishta Aktar; Yos Phanny; Mitsugu Todo
Journal:  J Mater Sci Mater Med       Date:  2019-11-29       Impact factor: 3.896

10.  Bone formation of human mesenchymal stem cells harvested from reaming debris is stimulated by low-dose bone morphogenetic protein-7 application in vivo.

Authors:  Fabian Westhauser; Melanie Höllig; Bruno Reible; Kai Xiao; Gerhard Schmidmaier; Arash Moghaddam
Journal:  J Orthop       Date:  2016-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.